Aerovate Therapeutics, Inc. (AVTE) - Quarterly Cash Flow Statement

Home
AVTE
Financials

1.98 (USD) • At close September 19, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Operating Activities:
Net Income Numbers are in millions	-24.775	-23.186	-20.413	-19.563	-19.025	-16.52	-15.022	-13.588	-11.991	-10.91	-8.223	-6.184	-5.775	-2.781	-3.666	-2.307	-2.202	-1.436
Depreciation & Amortization Numbers are in millions	0.028	0.028	0.028	0.025	0.022	0.021	0.02	0.02	0.017	0.011	0.008	0.003	0.002	0.002	0.001	0	0	0
Deferred Income Tax Numbers are in millions	0	0	-4.351	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stock Based Compensation Numbers are in millions	3.865	4.2	3.251	3.237	3.034	2.384	1.729	1.499	1.224	1.024	0.854	0.845	0.321	0.023	0.024	0.021	0.006	0.007
Change In Working Capital Numbers are in millions	1.141	-3.956	3.273	1.498	1.665	3.362	-1.006	2.641	1.935	4.185	-5.748	-1.19	1.447	-1.019	0.757	-0.211	0.26	0.168
Accounts Receivables Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Inventory Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Accounts Payables Numbers are in millions	0.948	0.835	-1.044	-2.014	0.773	2.121	-1.749	2.242	-0.712	1.587	-1.045	1.091	-0.202	0.765	0.007	-0.099	0.038	0.091
Other Working Capital Numbers are in millions	0.193	-4.791	4.317	3.512	0.892	1.241	0.743	0.399	2.647	2.598	-4.703	-2.281	1.649	-1.784	0.75	-0.112	0.222	0.077
Other Non Cash Items Numbers are in millions	2.281	2.662	3.412	-0.808	-0.639	-0.671	-0.586	-0.292	-0.061	0.029	0.016	-0.24	0.527	-0.738	0.007	0.064	0.577	0.078
Operating Cash Flow Numbers are in millions	-20.433	-23.673	-14.8	-15.611	-14.943	-11.424	-14.865	-9.72	-8.876	-5.661	-13.093	-6.526	-4.005	-3.775	-2.884	-2.433	-1.359	-1.183
Investing Activities:
Investments In Property Plant And Equipment Numbers are in millions	0	0	-0.064	-0.032	-0.03	-0.016	-0.004	-0.033	-0.13	-0.028	-0.085	-0.056	0	-0.04	0	0	0	0
Acquisitions Net Numbers are in millions	0	0	-0.006	0.013	-0.004	-0.015	-0.014	-0.005	-0.008	0	0	0	0	0	0	0	0	0
Purchases Of Investments Numbers are in millions	0	-14.75	-27.788	-47.848	-32.737	-15.609	-50.26	-25.572	-38.901	-32.89	-113.253	0	0	0	0	0	0	0
Sales Maturities Of Investments Numbers are in millions	18	23.583	33.5	34.75	36.75	31	64.75	30.25	47.225	12.519	0	0	0	0	0	0	0	0
Other Investing Activites Numbers are in millions	0	8.833	0.006	-0.013	0.004	0.015	0.014	0.005	0.008	-20.371	-113.253	0	0	0	0	0	0	0
Investing Cash Flow Numbers are in millions	18	8.833	5.648	-13.13	3.983	15.375	14.486	4.645	8.194	-20.399	-113.338	-0.056	0	-0.04	0	0	0	0
Financing Activities:
Debt Repayment Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Issued Numbers are in millions	24.38	0.471	0.463	0.02	45.29	0.223	0.15	0.037	0.002	0	-0.25	128.31	54.514	7.883	0	0	0	0
Common Stock Repurchased Numbers are in millions	0	0	0	0	0	0	0	0	0	0	-0.25	0	0	0	0	0	0	0
Dividends Paid Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing Activities Numbers are in millions	-0.074	-0.233	0	-0.075	0.045	0	0.207	0	0	0	-0.25	128.31	54.514	7.883	0	8.918	0	0
Financing Cash Flow Numbers are in millions	24.38	0.471	0.463	0.02	45.29	0.223	0.357	0.037	0.002	0	-0.25	128.31	54.514	7.883	0	8.918	0	0
Other Information:
Effect Of Forex Changes On Cash Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Change In Cash Numbers are in millions	21.947	-14.369	-8.689	-28.721	34.33	4.174	-0.022	-5.038	-0.68	-26.06	-126.681	121.728	50.509	4.068	-2.884	6.485	-1.359	-1.183
Cash At End Of Period Numbers are in millions	31.069	9.122	23.491	32.18	60.901	26.571	22.397	22.419	27.457	28.137	54.197	180.878	59.15	8.641	4.573	7.457	0.972	2.331

Aerovate Therapeutics, Inc.

NASDAQ:AVTE Add to watchlist

NASDAQ:AVTE